RxDoctor Payments Data

Caitlyn Costanzo, MD

Surgery · Newark, DENPI 1790075737

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (38.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 93.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $2,176 and has fallen 90.0% since, to $217 in 2025.

$5,203in general payments, 2019–2025

Across 62 payments — averaging $83.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • Medtronic$316
  • Johnson & Johnson$22
  • Teleflex LLC$18

What the payments were for

  • Travel & lodging$1,95538%
  • Food & beverage$1,23924%
  • Education$2,00038%
  • Gifts$90%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical48$4,847
Medtronic(2 entities)12$316
Johnson & Johnson1$22
Teleflex LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,203 in reported general payments places this provider in the 70th percentile of 89 surgery providers in Delaware.

See all surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$53,328
Medicare patients
119
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates18$1,226
Neomycin Sulfate11$53
Metronidazole15$39

Paid to pharmacies, not to this prescriber.

Other surgery in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →